Intellectual Property, net |
3 Months Ended | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Nov. 30, 2023 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Intellectual Property, net | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Intellectual Property |
6. Intellectual Property, net A continuity schedule for capitalized patents is presented below:
At November 30, 2023 the Company has capitalized a total of $494,377 of patents. Included in the capitalized costs is $480,762 of costs associated with patents and licenses that have been filed. Also included in the capitalized costs is $13,615 of costs associated with provisional patents and pending applications which have not yet been filed.
The Company evaluated its patent portfolio and determined that no pending applications have been abandoned or will not be pursued during the three months ended November 30, 2023. As such, no impairment loss has been recognized for the period. The Company recognized $8,274 of amortization expense related to patents and licenses in the three-months ended November 30, 2023 (2022 - $54,938). |
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||